BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Calker D, Biber K, Domschke K, Serchov T. The role of adenosine receptors in mood and anxiety disorders. J Neurochem 2019;151:11-27. [DOI: 10.1111/jnc.14841] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 9.7] [Reference Citation Analysis]
Number Citing Articles
1 Matthee C, Terre'Blanche G, Legoabe LJ, Janse van Rensburg HD. Exploration of chalcones and related heterocycle compounds as ligands of adenosine receptors: therapeutics development. Mol Divers 2021. [PMID: 34176057 DOI: 10.1007/s11030-021-10257-9] [Reference Citation Analysis]
2 Miao Z, Li Y, Mao F, Zhang J, Sun ZS, Wang Y. Prenatal witness stress induces intergenerational anxiety-like behaviors and altered gene expression profiles in male mice. Neuropharmacology 2021;202:108857. [PMID: 34728220 DOI: 10.1016/j.neuropharm.2021.108857] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Shinjyo N, Waddell G, Green J. Valerian Root in Treating Sleep Problems and Associated Disorders-A Systematic Review and Meta-Analysis. J Evid Based Integr Med 2020;25:2515690X20967323. [PMID: 33086877 DOI: 10.1177/2515690X20967323] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
4 Ju X, Wang S, Yan P, Zhu C, Hu X, Dong J, Tan Z. Rapid Eye Movement Sleep Deprivation Combined With Fluoxetine Protects Against Depression-Induced Damage and Apoptosis in Rat Hippocampi via A1 Adenosine Receptor. Front Psychiatry 2021;12:599399. [PMID: 34335318 DOI: 10.3389/fpsyt.2021.599399] [Reference Citation Analysis]
5 Serchov T, Schwarz I, Theiss A, Sun L, Holz A, Döbrössy MD, Schwarz MK, Normann C, Biber K, van Calker D. Enhanced adenosine A1 receptor and Homer1a expression in hippocampus modulates the resilience to stress-induced depression-like behavior. Neuropharmacology 2020;162:107834. [PMID: 31682853 DOI: 10.1016/j.neuropharm.2019.107834] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
6 Prowse N, Hayley S. Microglia and BDNF at the crossroads of stressor related disorders: Towards a unique trophic phenotype. Neurosci Biobehav Rev 2021;131:135-63. [PMID: 34537262 DOI: 10.1016/j.neubiorev.2021.09.018] [Reference Citation Analysis]
7 Samad N, Nasir A, Rehman MHU, Bhatti SA, Imran I. Adenosine protects D-galactose induced alterations in rat model of aging via attenuating neurochemical profile and redox status. Metab Brain Dis. [DOI: 10.1007/s11011-022-01049-7] [Reference Citation Analysis]
8 Zulkifly MFM, Merkohitaj O, Brockmöller J, Paulus W. Confounding effects of caffeine on neuroplasticity induced by transcranial alternating current stimulation and paired associative stimulation. Clin Neurophysiol 2021;132:1367-79. [PMID: 33762129 DOI: 10.1016/j.clinph.2021.01.024] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Aly J, Engmann O. The Way to a Human's Brain Goes Through Their Stomach: Dietary Factors in Major Depressive Disorder. Front Neurosci 2020;14:582853. [PMID: 33364919 DOI: 10.3389/fnins.2020.582853] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Fang C, Hayashi S, Du X, Cai X, Deng B, Zheng H, Ishido S, Tsutsui H, Sheng J. Caffeine protects against stress-induced murine depression through activation of PPARγC1α-mediated restoration of the kynurenine pathway in the skeletal muscle. Sci Rep 2021;11:7287. [PMID: 33790369 DOI: 10.1038/s41598-021-86659-4] [Reference Citation Analysis]
11 van Calker D, Serchov T. The "missing heritability"-Problem in psychiatry: Is the interaction of genetics, epigenetics and transposable elements a potential solution? Neurosci Biobehav Rev 2021;126:23-42. [PMID: 33757815 DOI: 10.1016/j.neubiorev.2021.03.019] [Reference Citation Analysis]
12 Almeida RF, Ferreira TP, David CVC, Abreu E Silva PC, Dos Santos SA, Rodrigues ALS, Elisabetsky E. Guanine-Based Purines as an Innovative Target to Treat Major Depressive Disorder. Front Pharmacol 2021;12:652130. [PMID: 33927625 DOI: 10.3389/fphar.2021.652130] [Reference Citation Analysis]
13 Pliássova A, Henriques M, Silva HB, Agostinho P, Cunha RA, Ferreira SG. Control of NMDA Receptor-Mediated Currents by Adenosine A 1 and A 2A Receptors Within the Basolateral Amygdala. Journal of Caffeine and Adenosine Research 2020;10:61-70. [DOI: 10.1089/caff.2019.0024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Bartoli F, Burnstock G, Crocamo C, Carrà G. Purinergic Signaling and Related Biomarkers in Depression. Brain Sci 2020;10:E160. [PMID: 32178222 DOI: 10.3390/brainsci10030160] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
15 Bertasi RAO, Humeda Y, Bertasi TGO, Zins Z, Kimsey J, Pujalte G. Caffeine Intake and Mental Health in College Students. Cureus 2021;13:e14313. [PMID: 33968523 DOI: 10.7759/cureus.14313] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Jenner P, Mori A, Kanda T. Can adenosine A2A receptor antagonists be used to treat cognitive impairment, depression or excessive sleepiness in Parkinson's disease? Parkinsonism & Related Disorders 2020;80:S28-36. [DOI: 10.1016/j.parkreldis.2020.09.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Peyton L, León BE, Essa H, Chern Y, Choi D. N6-substituated adenosine analog J4 attenuates anxiety-like behaviors in mice. Psychopharmacology. [DOI: 10.1007/s00213-022-06079-8] [Reference Citation Analysis]
18 Cai M, Liu W, Wu Y, Zheng Q, Liu D, Shi G. The serum uric acid is longitudinally related to patients global assessment of disease activity in male patients with axial spondyloarthritis. BMC Musculoskelet Disord 2022;23:717. [PMID: 35897055 DOI: 10.1186/s12891-022-05657-3] [Reference Citation Analysis]
19 Peng FZ, Fan J, Ge TT, Liu QQ, Li BJ. Rapid anti-depressant-like effects of ketamine and other candidates: Molecular and cellular mechanisms. Cell Prolif 2020;53:e12804. [PMID: 32266752 DOI: 10.1111/cpr.12804] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
20 Luo Z, Liao X, Luo L, Fan Q, Zhang X, Guo Y, Wang F, Ye Z, Luo D. Extracellular ATP and cAMP signaling promote Piezo2-dependent mechanical allodynia after trigeminal nerve compression injury. J Neurochem 2021. [PMID: 34757653 DOI: 10.1111/jnc.15537] [Reference Citation Analysis]
21 Charvériat M, Guiard BP. Serotonergic neurons in the treatment of mood disorders: The dialogue with astrocytes. Prog Brain Res 2021;259:197-228. [PMID: 33541677 DOI: 10.1016/bs.pbr.2021.01.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Chellappa SL, Aeschbach D. Sleep and anxiety: From mechanisms to interventions. Sleep Med Rev 2021;61:101583. [PMID: 34979437 DOI: 10.1016/j.smrv.2021.101583] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
23 Reichert CF, Deboer T, Landolt HP. Adenosine, caffeine, and sleep-wake regulation: state of the science and perspectives. J Sleep Res 2022. [PMID: 35575450 DOI: 10.1111/jsr.13597] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Xiao SY, Liu YJ, Lu W, Sha ZW, Xu C, Yu ZH, Lee SD. Possible Neuropathology of Sleep Disturbance Linking to Alzheimer's Disease: Astrocytic and Microglial Roles. Front Cell Neurosci 2022;16:875138. [PMID: 35755779 DOI: 10.3389/fncel.2022.875138] [Reference Citation Analysis]
25 Lew SY, Lim SH, Lim LW, Wong KH. Neuroprotective effects of Hericium erinaceus (Bull.: Fr.) Pers. against high-dose corticosterone-induced oxidative stress in PC-12 cells. BMC Complement Med Ther 2020;20:340. [PMID: 33176761 DOI: 10.1186/s12906-020-03132-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
26 Szopa A, Socała K, Serefko A, Doboszewska U, Wróbel A, Poleszak E, Wlaź P. Purinergic transmission in depressive disorders. Pharmacol Ther 2021;224:107821. [PMID: 33607148 DOI: 10.1016/j.pharmthera.2021.107821] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Bauer EE, Buhr TJ, Reed CH, Clark PJ. Exercise-Induced Adaptations to the Mouse Striatal Adenosine System. Neural Plast 2020;2020:5859098. [PMID: 32399024 DOI: 10.1155/2020/5859098] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Martins HC, Schratt G. Depression: a new enzyme AT play. EMBO Rep 2020;21:e49921. [PMID: 32133721 DOI: 10.15252/embr.201949921] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Pasquini S, Contri C, Merighi S, Gessi S, Borea PA, Varani K, Vincenzi F. Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets. Int J Mol Sci 2022;23:1219. [PMID: 35163142 DOI: 10.3390/ijms23031219] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
30 Govindula A, Pai A, Baghel S, Mudgal J. Molecular mechanisms of cordycepin emphasizing its potential against neuroinflammation: An update. Eur J Pharmacol 2021;908:174364. [PMID: 34297967 DOI: 10.1016/j.ejphar.2021.174364] [Reference Citation Analysis]
31 Gonçalves MCB, Andrejew R, Gubert C. The Purinergic System as a Target for the Development of Treatments for Bipolar Disorder. CNS Drugs 2022. [PMID: 35829960 DOI: 10.1007/s40263-022-00934-0] [Reference Citation Analysis]
32 de Bartolomeis A, Barone A, Buonaguro EF, Tomasetti C, Vellucci L, Iasevoli F. The Homer1 family of proteins at the crossroad of dopamine-glutamate signaling: An emerging molecular "Lego" in the pathophysiology of psychiatric disorders. A systematic review and translational insight. Neurosci Biobehav Rev 2022;136:104596. [PMID: 35248676 DOI: 10.1016/j.neubiorev.2022.104596] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Lintunen J, Lähteenvuo M, Tanskanen A, Tiihonen J, Taipale H. Allopurinol, dipyridamole and calcium channel blockers in the treatment of bipolar disorder - A nationwide cohort study. J Affect Disord 2022:S0165-0327(22)00700-5. [PMID: 35753501 DOI: 10.1016/j.jad.2022.06.040] [Reference Citation Analysis]
34 Gonçalves MCB, Glaser T, Oliveira SLBD, Ulrich H. Adenosinergic-Dopaminergic Signaling in Mood Disorders: A Mini-Review. Journal of Caffeine and Adenosine Research 2020;10:94-103. [DOI: 10.1089/caff.2020.0009] [Reference Citation Analysis]
35 Gomes JI, Farinha-Ferreira M, Rei N, Gonçalves-Ribeiro J, Ribeiro JA, Sebastião AM, Vaz SH. Of adenosine and the blues: The adenosinergic system in the pathophysiology and treatment of major depressive disorder. Pharmacol Res 2021;163:105363. [PMID: 33285234 DOI: 10.1016/j.phrs.2020.105363] [Reference Citation Analysis]
36 Zhao Y, Zhang H, Zhang Y, Fang Z, Xu C. Rapid Eye Movement Sleep Deprivation Enhances Adenosine Receptor Activation and the CREB1/YAP1/c-Myc Axis to Alleviate Depressive-like Behaviors in Rats. ACS Chem Neurosci 2022. [PMID: 35838172 DOI: 10.1021/acschemneuro.2c00167] [Reference Citation Analysis]